115 related articles for article (PubMed ID: 2538850)
21. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
Weithmann KU
Gen Pharmacol; 1983; 14(1):161-2. PubMed ID: 6298055
[TBL] [Abstract][Full Text] [Related]
22. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
Manrique RV; Manrique V
Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
[TBL] [Abstract][Full Text] [Related]
23. [Effects of neferine on platelet aggregation in rabbits].
Yu J; Hu WS
Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
[TBL] [Abstract][Full Text] [Related]
24. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
25. Platelet function in classic migraine during attack-free periods.
Hedman C; Winther K; Knudsen JB
Acta Neurol Scand; 1988 Oct; 78(4):271-7. PubMed ID: 2851913
[TBL] [Abstract][Full Text] [Related]
26. Studies on the characterization of the subtype(s) of muscarinic receptor involved in prostacyclin synthesis in rabbit cardiomyocytes.
Tyagi MG; Kan H; Ruan Y; Malik KU
J Recept Signal Transduct Res; 1996; 16(5-6):273-96. PubMed ID: 8968962
[TBL] [Abstract][Full Text] [Related]
27. Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome.
Schlegel N; Maclouf J; Loirat C; Drouet L; Marotte R; Scarabin PY; Mathieu H
J Pediatr; 1987 Jul; 111(1):71-7. PubMed ID: 3298597
[TBL] [Abstract][Full Text] [Related]
28. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin.
Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW
Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766
[TBL] [Abstract][Full Text] [Related]
29. The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.
White DG; Mundin JW; Sumner MJ; Watts IS
Br J Pharmacol; 1993 Aug; 109(4):1128-32. PubMed ID: 8401924
[TBL] [Abstract][Full Text] [Related]
30. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
Nogimori K; Kajikawa N; Nishio S; Yajima M
Prostaglandins; 1989 Feb; 37(2):205-12. PubMed ID: 2543034
[TBL] [Abstract][Full Text] [Related]
31. VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF).
Cox CP; Linden J; Said SI
Peptides; 1984; 5(2):325-8. PubMed ID: 6206481
[TBL] [Abstract][Full Text] [Related]
32. Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation.
Greer IA; McLaren M; Forbes CD
Eur J Obstet Gynecol Reprod Biol; 1990; 35(2-3):109-18. PubMed ID: 1970789
[TBL] [Abstract][Full Text] [Related]
33. Prostacyclin and thromboxane formation in human umbilical arteries following stimulation with vasoactive autacoids.
Bjøro K
Prostaglandins; 1986 Apr; 31(4):699-714. PubMed ID: 3523624
[TBL] [Abstract][Full Text] [Related]
34. Plasma factors influencing PGI2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura.
Túri S; Nagy J; Haszon I; Havass Z; Németh M; Bereczki C
Pediatr Nephrol; 1989 Jan; 3(1):61-7. PubMed ID: 2518449
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris.
Kishi Y; Ashikaga T; Numano F
Am Heart J; 1992 Feb; 123(2):291-7. PubMed ID: 1736562
[TBL] [Abstract][Full Text] [Related]
36. Antithrombotic effects of endocardial endothelial cells-comparison with coronary artery endothelial cells.
Nosaka S; Hashimoto M; Sasaki T; Ku K; Saitoh Y; Hanada T; Yamauchi M; Masumura S; Nakayama K; Tamura K
Prostaglandins; 1997 May; 53(5):305-19. PubMed ID: 9247971
[TBL] [Abstract][Full Text] [Related]
37. Platelet rap1B phosphorylation is a sensitive marker for the action of cyclic AMP- and cyclic GMP-increasing platelet inhibitors and vasodilators.
Grünberg B; Kruse HJ; Negrescu EV; Siess W
J Cardiovasc Pharmacol; 1995 Apr; 25(4):545-51. PubMed ID: 7596121
[TBL] [Abstract][Full Text] [Related]
38. Cocaine use and its effect on umbilical artery prostacyclin production.
Cejtin HE; Parsons MT; Wilson L
Prostaglandins; 1990 Sep; 40(3):249-57. PubMed ID: 2247615
[TBL] [Abstract][Full Text] [Related]
39. Reduction of prostacyclin synthesis as a possible cause of transient flow reduction in a partially constricted canine coronary artery.
Tada M; Esumi K; Yamagishi M; Kuzuya T; Matsuda H; Abe H; Uchida Y; Murao S
J Mol Cell Cardiol; 1984 Dec; 16(12):1137-49. PubMed ID: 6398370
[TBL] [Abstract][Full Text] [Related]
40. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
Miller OV; Aiken JW; Shebuski RJ; Gorman RR
Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
